Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
George Yancopoulos
Biotech
Regeneron to fill gaps in obesity, break ground in cell therapy
Regeneron wants to improve on obesity care with a muscle-preservation approach, while elsewhere, the biopharma charts a new course in cell therapy.
Annalee Armstrong
Feb 2, 2024 10:25am
Fierce Biotech's Rotten Tomatoes of 2022
Dec 19, 2022 3:00am
Regeneron exec draws boos as he touts innovation over cost
Dec 8, 2022 11:50pm
Regeneron pinpoints gene variants that protect against obesity
Jul 1, 2021 2:00pm
Regeneron has spoken with the FDA about odronextamab hold
Jan 11, 2021 9:35am
Regeneron's COVID-19 antibody speeds recovery in early data
Sep 29, 2020 10:04pm